Epstein-Barr virus (EBV) infection visualized by EGFP expression demonstrates dependence on known mediators of EBV entry

Archives of Virology

Volumn 144, Issue 6, 1999, Pages 1123-1137

  Speck, P ^a   Longnecker, R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CELL RECEPTOR; EPSTEIN BARR VIRUS; GREEN FLUORESCENT PROTEIN; PATHOGENESIS; REPORTER GENE; T LYMPHOCYTE; TUMOR CELL LINE; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 0032782171     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050574     Document Type: Article

References (43)

1. Alexander IE, Russell DW, Miller AD (1997) Transfer of contaminants in adenoassociated virus vector stocks can mimic transduction and lead to artifactual results. Hum Gene Ther 8: 1 911-1 920
2. Chalfie M (1995) Green fluorescent protein. Photochem Photobiol 62: 651-656
3. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC (1994) Green fluorescent protein as a marker for gene expression. Science 263: 802-805
4. Chang RS, Lung ML (1994) A modified procedure for the propagation of wild type Epstein-Barr virus in cultures of marmoset blood cells. J Virol Methods 46: 167-178
5. Cormack BP, Valdivia RH, Falkow S (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33-38
6. Deev SM, Combriato G, Klobeck HG, Zachau HG (1987) Reciprocal recombination products of VK-JK joining reactions in human lymphoid cell lines. Nucleic Acids Res 15: 1-14
7. Epstein MA, Achong BG, Barr YM, Zajac B, Henle G, Henle W (1966) Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst 37: 547-559
8. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81: 4510-4514
9. Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146: 865-869
10. Frade R, Barel M, Ehlin-Henriksson B, Klein G (1985) gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Proc Natl Acad Sci USA 82: 1490-1493
11. Groux H, Cottrez F, Montpellier C, Quatannens B, Coll J, Stehelin D, Auriault C (1997) Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood 89: 4521-4530
12. Guan M, Zhang RD, Wu B, Henderson EE (1996) Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression. J Virol 70: 7341-7346
13. Heim R, Cubitt AB, Tsien RY (1995) Improved green fluorescence [Letter]. Nature 373: 663-664
14. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318: 733-741
15. Kieff E (1996) Epstein Barr virus and its replication. In: Fields B, Knipe D, Howley P (eds) Fundamental virology. Raven Press, New York, pp 1109-1162
16. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osata T, Kobayashi I, Hamada I, Hirai K (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333: 455-457
17. Klein G, Clements G, Zeuthen J, Westman A (1976) Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Int J Cancer 17: 715-724
18. Klein G, Giovanella B, Westman A, Stehlin JS, Mumford D (1975) An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5: 319-334
19. Klein G, Lindahl T, Jondal M, Leibold W, Menezes J, Nilsson K, Sundstrom C (1974) Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci USA 71: 3283-3286
20. Koizumi S, Zhang XK, Imai S, Sugiura M, Usui N, Osato T (1992) Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Virology 188: 859-863
21. Li Q, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B, Hutt-Fletcher LM (1997) Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71: 4657-4662
22. Liu ML, Winther BL, Kay MA (1996) Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 70: 2497-2502
23. Longnecker R (1998) Molecular biology of Epstein-Barr virus. In: McCance D (ed) Human tumor viruses. ASM Press, Washington, pp 133-172
24. Longnecker R, Miller CL, Miao X-Q, Tomkinson B, Kieff E (1993) The last seven transmembrane and carboxy terminal tail of Epstein-Barr virus latent membrane 2 (LMP2) are dispensable for lymphocyte infection and growth transformation. J Virol 67: 2006-2013
25. Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70: 190-194
26. Miller G, Shope T, Lisco H, Stitt D, Lipman M (1972) Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci USA 69: 383-387
27. Nemerow GR, Wolfert R, McNaughton ME, Cooper NR (1985) Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55: 347-351
28. Nyormoi O, Klein G, Adams A, Dombos L (1973) Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line. Int J Cancer 12: 396-408
29. Okano M, Taguchi Y, Nakamine H, Pirruccello SJ, Davis JR, Beisel KW, Kleveland KL, Sanger WG, Fordyce RR, Purtilo DT (1990) Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol 137: 517-522
30. Rickinson A, Kieff E (1996) Epstein-Barr virus. In: Fields B, Knipe D, Howley P, Chanock R, Melnick J, Monath T, Roizman B, Straus S (eds) Fields Virology, vol 2, 3rd ed. Lippincott-Raven, Philadelphia, pp 2397-2446
31. Sauvageau G, Stocco R, Kasparian S, Menezes J (1990) Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes. J Gen Virol 71: 379-386
32. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K (1994) Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68: 6069-6073
33. Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, Macduff B, Ulrich D, Alderson MR, Mullberg J, Cohen JI (1996) The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol 70: 5557-5563
34. Stevenson M, Volsky B, Hedenskog M, Volsky DJ (1986) Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science 233: 980-984
35. Stocco R, Sauvageau G, Menezes J (1988) Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction. Virus Res 11: 209-225
36. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY (1991) Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 77: 799-808
37. Su IJ, Lin KH, Chen CJ, Tien HF, Hsieh HC, Lin DT, Chen JY (1990) Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype. Cancer 66: 2557-2562
38. Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF (1986) Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system. J Immunol 137: 1387-1391
39. Tsoukas CD, Lambris JD (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18: 1299-1302
40. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 64: 2309-2318
41. Wang X, Hutt-Fletcher LM (1998) Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72: 158-163
42. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD (1991) Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173: 971-980
43. Ziegler A, Heinig J, Muller C, Gotz H, Thinnes FP, Uchanska-Ziegler B, Wernet P (1986) Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22, 34, 35, 36, 37, 39, 43, 58 and YD 1/63. HLK directed against human HLA class II antigens. Immunobiology 171: 77-92